CIN2和主动监测:HPV阳性队列48个月随访的证据
Maria Teresa Bruno1, Antonino Giovanni Cavallaro1, Alessia Pagana1
1Department of General Surgery and Medical Surgery Specialties, Gynecological Clinic, University of Catania, 95123 Catania, Italy.
Cancers
|December 11, 2025
概括
对于许多人来说,宫内皮质瘤2级 (CIN2) 的积极监测是有效的,但高度细胞学和HPV 16/18感染表明进展风险更高. 持续超过36个月也表明风险增加.
科学领域:
- 妇科 妇科医生 妇科
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 建议对2级子宫内皮质瘤 (CIN2) 进行保守的治疗,特别是对于年轻的,正在寻求生育的女性.
- 识别患病进展高风险的CIN2子组对于有效的长期监测策略至关重要.
研究的目的:
- 评估HPV阳性女性中CIN2的临床过程,在多达48个月的积极监测下.
- 为了确定CIN2进展,持久性和回归的预测因素.
主要方法:
- 对237名被诊断患有CIN2.2的HPV阳性女性进行了回顾性研究.
- 结果 (进展,持久性,回归) 通过结构化的随访 (细胞学,肠镜检查,HPV检测) 进行分析.
- 后勤回归用于确定进展和回归的独立预测因素.
主要成果:
- 在61.3%的病例中观察到自发回归;13.1%持续;25.5%进展到CIN3.
- 高度细胞学 (ASC-H/HSIL) 和HPV 16/18感染与较低的回归率和更高的进展率有关.
- 在随访期间,没有侵袭性宫癌发展.
结论:
- 积极监测是选择CIN2患者的可行策略,但并不普遍安全.
- 通过高等级细胞学和HPV 16/18确定的高风险概况要求立即治疗.
- 持续超过36个月是一个风险标志,为个性化管理和后续行动提供信息.
更多相关视频
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
28.1K
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.9K
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
